Category Archives: IPR

Ingredients for WHO roadmap on access to medicines at civil society side event

Source: Intellectual Property Watch | May 25, 2018 On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the … Continue reading

Posted in Access to Medecines, Cancer, IPR, TRIPS, WHO | Leave a comment

Why the US and pharmaceutical giants want a provision in India’s patent law revoked

Source: | May 02, 2018 India’s patent laws are under attack again. This time, too, the target is a provision not commonly found in patent laws elsewhere. This rule requires patent holders to disclose whether they are working their … Continue reading

Posted in Generics, Indian Patent Law, IPR, Patents | Leave a comment

U.S. wants patent form recall

Source: The Hindu | April 15, 2018 Submission on interpretation of a domestic patent law raises eyebrows The United States Patent and Trademark Office (USPTO) has demanded the elimination of ‘Form 27’— a statutory requirement unique to India’s patent law … Continue reading

Posted in Indian Patent Law, Indian Patent Office, IP Rights, IPR, Patent Enforcement, Patent infringement, US pressure on India | Leave a comment

MSF statement on resumption of EU-India FTA negotiations

Source: MSF Access Campaign | 11 April 2018 Officials from the European Union (EU) and India are expected to meet in Brussels on April 12th to resume technical talks on the long-stalled EU-India free trade agreement (FTA). A leaked draft … Continue reading

Posted in EU-India FTA, IPR, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WTO | Leave a comment

EC publishes report on protection and enforcement of intellectual property rights in “third countries”

Source: Knowledge Ecology International   | March 14, 2018 On March 12, 2018, the European Commission published a report on the “protection and enforcement of intellectual property rights in third countries”. The main objective of the report “is to identify third countries … Continue reading

Posted in IPR, Uncategorized | Leave a comment

The scalpels are out ahead of ‘Special 301’ Report

 by PT Jyothi Datta | The HinduBusinessLine Indian pharma pushes back against US trade body’s criticism of its IPR protection record For the past five years, a lone Indian pharmaceutical representation goes out to the Office of the US Trade … Continue reading

Posted in IPR, Special 301 report, Uncategorized | Leave a comment

How Meaningful Is India’s Improved Ranking On Intellectual Property Index?

By Payaswini Upadhyay, Source: BloombergQuint | February 12, 2018 India’s ranking improved among 50 countries in the annual International IP Index this year on better protection for trademarks and copyrights and easier rules to patent computer-related innovations. The U.S. Chamber of Commerce … Continue reading

Posted in IPR, Uncategorized | Leave a comment